期刊文献+

呼吸机相关肺炎36例临床分析 被引量:6

Clinical analysis of 36 rentilator-associated pneumonia
下载PDF
导出
摘要 目的探讨呼吸机相关肺炎(VAP)的致病因素、病原菌分布、治疗及预防措施。方法回顾性分析36例VAP患者临床资料、致病菌及治疗方案等。结果 VAP发生率为5.5%,病死率为22.2%。主要致病菌为革兰阴性杆菌(66.0%),以铜绿假单胞菌、肺炎克雷伯菌和大肠埃希菌为主;革兰阳性球菌占25.5%,主要为金黄色葡萄球菌;真菌占8.5%,主要为白色念珠菌。结论对机械通气患者采取积极有效预防,及时有效应用抗菌药治疗和综合治疗,可以减少VAP发生率,降低病死率。 Objective To investigate the etiological factors,pathogenic bacterium,measure of treatment and prevention.Methods The clinic data,pathogenic bacterium and therapeutic regimen of 36 patients suffered from ventilator-associated pneumonia(VAP) were analyzed retrospectively.Results The incidence rate of VAP and mortality rate in this group was 5.5% and 22.2% respectively.The main pathogenic bacterium were Gram-Negative bacillus,which taken up of 66.0%,and commonlly included Pseudomonas aeruginosa,klebsiella pneumoniae and escherichaiacoli.Gram-positive coccus and eumycete were hold 25.5% and 5.5%respectively.The former were chiefly Staphylococcus aureus and the later were Blastomyces albicans.Conclusion Active prevention,effective antibiotics and combined therapy can decrease the incidence rate of VAP and cut down mortality rate.
机构地区 解放军
出处 《重庆医学》 CAS CSCD 北大核心 2010年第16期2192-2193,共2页 Chongqing medicine
关键词 呼吸机相关肺炎 致病菌 临床分析 ventilator-associated pneumonia pathogen clinical analysis
  • 相关文献

参考文献6

二级参考文献10

共引文献2242

同被引文献47

  • 1李乃庆,秦红.呼吸机相关肺炎32例分析[J].柳州医学,2007,20(1):25-27. 被引量:7
  • 2中华医学会呼吸病学分会.急性肺损伤/急性呼吸窘迫综合征的诊断标准(草案)[J].中华结核和呼吸杂志,2000,23(4):203-203.
  • 3Miller PR,Croce MA,Kilgo PD,et al.Acute respiratory distress syndrome in blunt trauma:identification of independent risk factors.Am Surg,2002,68(10):845-850.
  • 4Masterton RG, Galloway A, French G, et al. Guidelines for the management of hospital-acquired pneumonia in the UK : report of the working party on hospital-acquired pneumonia of the British So- ciety for Antimicrobial Chemotherapy [ J ]. J Antimicrob Chemoth- er,2008,62( 1 ) :5-34.
  • 5Abrahamian FM, Deblieux PM, Emerrnan CL, et al. Health care-as- sociated pneumonia:identification and initial management in the E D[J]. Am J Emerg Med,2008,26(6 Suppl) :l-ll.
  • 6Foglia E, Meier MD, Elward A. Ventilator-associated pneumonia in neonatal and pediatric intensi-e care unit patients[ J ]. C|in Micro- biol Rev,2007,20 (3) :409-425.
  • 7Jones RN. Microbial etiologies of hospital-acquired bacterial pneu- monia and ventilator-associated bacterial pneumonia [ J ]. Clin In- fect Dis,2010,51 ( Suppl 1 ) :$81-87.
  • 8Castanheira M, Sader HS, Deshpande LM, a al. Antimicrobial ac- tivities of tigecycline and other broad-spectrum antimicrobials test- ed against serine carbapenemase-and metallo-beta-lactamase-pro- dut:ing Enterobacteriacea: report from the SENTRY Antimicrobial Surveillance Program [ J ]. Antimicrob Agents Chemother, 2008,52 ( 2 ) 570 -573.
  • 9KoUef MH,Shorr A,Tabak YP,et al. Epidemiology and outcomes of health-care-associated pneumonia:results from a large US database of culture-positive pneumonia[ J ]. Chest,2005,128 ( 6 ) :3854-3862.
  • 10Jones RN. Global epidemiology of antimierobial resistance among community-acquired and nosocomial pathogens:a five-year summa- ry from the SENTRY Antimicrobial Surveillance Program (1997- 2001 ) [ J]. Semin Respir Crit Care Med ,2003,24 ( 1 ) :121-134.

引证文献6

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部